The AboutPharma Digital Awards represent the most important award in Italy dedicated to projects that enhance digital implementation in healthcare

Projects conceived or developed by the following can apply for the award:

THE CATEGORIES

Clinical research

Purpose: facilitate and enhance clinical research through digital tools that support the design and implementation of clinical trials, both randomised and real-world.

Target audience: researchers, clinicians, patients, funders

Types and examples: projects that facilitate one or more of the different aspects of a clinical trial: study design, ethics committee approval, funding, patient recruitment, treatment administration, data collection and analysis, work drafting and presentation.

In particular, projects using digital for Big Data and advanced analysis, remote monitoring, modelling and simulation: digital biobanks, integration of clinical data from different sources, sharing results in real time, artificial intelligence and machine learning, data security and privacy, etc.

This includes all types of trials, classic and innovative (RCTs; observational studies, real world data, decentralised trials, virtual trials, etc.), studies of digital medicines, digital therapeutics, and all other digital health technologies.

Communication towards citizens and patients

Purpose: communicate from a corporate, therapeutic area or product perspective to citizens and patients

Target audience: citizens, patients, patient associations, students of all school grades,

Types and examples: public awareness projects on topics of crucial interest to the national economic system and on specific topics such as rare diseases, disability, etc.; dissemination projects on digital culture in healthcare, education projects on specific digital health topics, wellness and disease awareness projects.

All types of multi-channel communication are included. Examples: video, podcasts and moviemaking, PR and brand storytelling, mobile and apps marketing, insight and market research, data-driven marketing, content marketing, branded experiences and events, search marketing, social media, sponsorship and partner marketing

Some projects described in the categories “Wellness, prevention, quality of life”, “Improving patient care” and “Patient engagement and advocacy” fall into this category when the communicational aspects of the project, developed through social and other digital channels, are prevalent

Telemedicine

Purpose: implement telemedicine solutions according to the Ministry of Health guidelines

Target audience: doctors, other healthcare professionals, patients, payors, institutions

Types and examples: all projects using one or more of the different forms of telemedicine (televisit, teleconsultation, telehealth, teleassistance, etc.) for prevention, diagnosis, treatment, rehabilitation and monitoring.

Projects that contribute to a better quality of care by ensuring continuity of care, greater effectiveness, efficiency, appropriateness, equity of access to health care (i.e. in rural and remote areas), drug therapy support to improve drug compliance.

Projects that help the patient in the therapeutic process and reduce adverse drug events, and for all other activities where telemedicine plays an important role in improving the quality of care.

Updating and training doctors

Purpose: help the doctor in his/her continuous training and learning of new diagnostic and therapeutic techniques and technologies

Target audience: doctors, both GPs and specialists

Types and examples: projects that use innovative tools (e.g. virtual meetings, artificial intelligence, augmented reality, simulations, big data analysis, metaverse, etc.) to help the doctor in his/her training. In particular, projects that foster the doctor’s understanding of the main digital health tools, improve the doctor’s knowledge of the main diagnostic and therapeutic innovations, optimise the doctor’s adherence to regulations, improve the doctor’s understanding of the socio-economic health impact of his/her decisions, improve the doctor’s skills in his/her therapeutic area and/or the doctors’ soft skills, and foster effective collaboration between GPs and specialists and between doctors and other stakeholders

Improving patient care

Purpose: promote effective and efficient treatment of diseases

Target audience: doctors, pharmacists, other healthcare professionals, payors

Types and examples: Projects that exploit digital technology in a broad sense to improve patient care through better identification of diseases, optimisation of diagnosis, setting and follow-up of drug therapy and the use of medical devices. Examples: projects applying artificial intelligence and machine learning to diagnosis and therapy; use of remote monitoring technologies, augmented reality, virtual reality, simulation, 3D printing, blockchain; projects adapting technologies used in other sectors to medical topics, use of advanced therapies, digital medicines, digital therapeutics and all other technologies specifically focused on patient care. Projects promoting the value of a health technology. Collaborative projects between clinicians, payors and patients. Projects aimed at quantifying expenditure budgets at different levels (hospital, local health authority, region, etc.).

Digital in ESG

Purpose: use digital technologies to improve the Environmental, Social, and Governance (ESG) performance of a company, or a place of care, or an institution to achieve greater operational efficiency, a better corporate reputation, a greater ability to adapt to the sustainable challenges of the future, and greater investor confidence.

Target audience: company staff, institutions, citizens, patients, associations, environment, health ecosystem

Types and examples: Projects where digital plays a key role in improving a company’s ESG (Environmental, Social, and Governance) performance. Examples:

  • Environmental monitoring and impact reduction: such as energy use management, resource optimisation, emission reduction and pollution monitoring.
  • Transparency and communication: using digital channels, such as its website, social media and ESG reporting platforms, to share information regarding its policies, actions and progress on environmental, social and governance issues.
  • Involvement of stakeholders, including employees, customers, suppliers and investors, in ESG initiatives through digital forms of interaction
  • Social innovation: for example online platforms for crowdfunding, creating partnerships with non-profit organisations or institutions to tackle specific social problems.
  • Diversity and inclusion: monitoring of staff diversity, online training on cultural sensitivity and promotion of an inclusive work environment.
  • Governance and transparency: projects that facilitate the traceability of decisions, thereby improving accountability and overall corporate governance.
  • Reporting and performance evaluation to collect data from various sources, calculate sustainability indicators and generate accurate and timely ESG reports for investors and other stakeholders.
Wellness, prevention, quality of life

Purpose: promote the well-being of citizens and the primary and secondary prevention of diseases, to improve the quality of life of patients and their caregivers

Target audience: citizens and patients

Types and examples: projects that promote psychophysical well-being and a correct lifestyle; projects that measure the state of well-being, identify risk factors and facilitate their correction; projects that improve disease management by patients and their caregivers. Projects to measure PROs (patient reported outcomes) and their significance. Included in this category are primary prevention projects, which are aimed at citizens who do not have overt diseases, and secondary prevention projects in patients with chronic diseases

Communication towards the healthcare professional

Purpose: communicate from a corporate, therapeutic area or product perspective to the healthcare professional target audience

Target audience: doctors, pharmacists, veterinarians, other healthcare professionals

Types and examples: disease awareness projects, wide-ranging education projects on digital health topics, projects to raise awareness among HCPs on issues relevant to their clinical practice, projects that focus HCPs’ attention on economic and environmental sustainability and other topics of crucial interest to the national system.

All types of multi-channel communication are included. Examples: video, podcasts and moviemaking, PR and brand storytelling, mobile and apps marketing, insight and market research, data-driven marketing, content marketing, branded experiences and events, search marketing, social media, sponsorship and partner marketing.

Projects that have already been submitted in the categories “Improving patient care” and “Supporting the medical profession”, and “HTA, healthcare supply and care” are also eligible for application in this category when the communication aspects of the project, through social and other digital channels, are prevalent.

Artificial Intelligence Application

Purpose: implement different forms of artificial intelligence in digital health projects

Target audience: doctors, other healthcare professionals, patients, payors, institutions, companies

Types and examples: all projects that use one or more of the various forms of artificial intelligence to improve one or more aspects of digital health:

  • In the identification and research of new molecules
  • In clinical research of drugs and medical devices
  • In the prevention and diagnosis of diseases
  • In the facilitation of the visit, from history taking to reporting
  • In therapy setting and monitoring, in all phases of the patient journey and in pharmacovigilance
  • In written and verbal communication between HCPs and between HCP and patient, as a support to doctors, pharmacists, nurses and all other HCPs involved in care delivery
  • In improving the regulatory compliance of all forms of communication
  • In any other situation where artificial intelligence may prove useful in improving healthcare delivery and care
Supporting the medical profession

Purpose: facilitate updating and provide support tools for the practice and profession of pharmacists

Target audience: community and hospital pharmacists

Types and examples: projects that help the management of the pharmacist’s activity, both territorial and hospital. Projects that reduce the risks associated with drug management, particularly at the intra-hospital level.

Projects that promote the role of the service pharmacy, promote the culture of galenic preparations, foster effective collaboration with healthcare managers, doctors, and caregivers, and promote understanding of key digital health tools.

Projects that implement innovative drug distribution practices, promote e-commerce, and counter the phenomenon of fake medicines; projects that promote a One Health culture and help pharmacists involved in animal health work with veterinarians and other stakeholders to optimise pets health.

HTA, healthcare supply and care

Purpose: optimise access to new therapeutic solutions and the provision of services for citizens and patients at all stages of the patient journey by facilitating the availability and access of citizens to diagnostic and treatment facilities and improving follow up and overall disease management

Target audience: doctors, pharmacists, other healthcare professionals, payors

Types and examples: Health technology assessment (HTA) projects in the broadest sense, projects for the creation, development and implementation of validated and innovative Diagnostic Therapeutic Care Pathways (PDTA). Projects to improve healthcare provision at all levels and at all stages of the patient journey: visibility and ways of booking services, referral and diagnosis, choice and setting therapy to patient monitoring and follow-up. Patient access and patient support program projects, optimisation of the organisation of healthcare provision in hospitals and nursing homes, projects to improve access to drugs and medical devices. All projects in the category “improvement of patient care” in which the organisational management aspect, defined as “care”, over the act of caring, “cure” in the narrower sense, is prevalent, can also apply in this category

Digital transformation and Industry 4.0

Purpose: improve business processes through digital transformation and 4.0 enabling technologies in the Life Science supply chain, in order to achieve greater competitiveness, flexibility, sustainability, compliance, productivity, speed and reliability of processes for the ultimate benefit of patients

Target audience: all functional areas (including planning, logistics, production, supply chain, quality assurance, laboratories, regulatory, clinical, pharmacovigilance, safety) of companies in the healthcare sector, from research and development, production and distribution to the point of use in healthcare facilities

Types and examples: digital transformation and Industry 4.0 projects aimed at improving business processes:

  • Vertical and horizontal integration of digital systems and 4.0 enabling technologies, automation of machinery, devices, instruments, sensors for collecting and processing production/logistics/quality parameters
  • Dynamic and scenario-based planning and scheduling of initiatives, products, projects and resources, e.g. for production, laboratories, research
  • Management and execution of paperless production integrated with machines/sensors and other management systems (including ERP, LIMS, QMS, WMS)
  • Automation of business processes and documents or business process & content management
  • Logistics and materials handling using collaborative robots, automated warehouses, IOT, etc.
  • Management of analysis laboratories (LIMS/LES/ELN), both research and quality control
  • Management and analysis of scientific data from discovery to analysis in research laboratories
  • Collection, historicisation and analysis of big data, for predictive and adaptive analysis,
  • Enterprise asset management with innovative tracking tools, including real-time location and data collection, predictive analysis for maintenance, etc.

Use of 4.0 enabling technologies of particular interest including:

  • Multitenant cloud, (maintenance, serialisation, quality assurance, pharmacovigilance, regulatory, production); machine learning and artificial intelligence for data interpretation, guidance and decision support for operators and managers; blockchain for distribution traceability, drug sample management for doctors, information sharing with partners and end users; digital twin and simulation for plant and utilities design, for production and logistics planning scenarios, for process optimisation; additive manufacturing or 3D printing; collaborative robots for optimising line operations; augmented and virtual reality, wearable devices and voice recognition for design integration, maintenance support and procedure execution, training implementation, etc…
Patient engagement and advocacy

Purpose: improve overall disease management through engagement and/or advocacy actions at all stages: screening, diagnosis, treatment, follow-up.

Target audience: patients, caregivers, other stakeholders

Types and examples: projects that promote patients’ understanding of their disease and improve their management of it; projects that promote a patient’s lifestyle appropriate to their clinical situation; training and/or management tools for patients, relatives and caregivers in order to achieve a resolution of the disease or an improvement in prognosis: projects that help patients to receive an optimal healthcare offer, etc.

Communication towards institutions

Purpose: communicate both from a corporate and therapeutic area perspective to institutional and healthcare governance targets

Target audience: health institutions, payors, other governance entities relevant to human and animal health

Types and examples: projects to raise awareness of institutions on issues of crucial interest to the national system, and on specific topics such as rare diseases, disability, etc., projects focusing on economic and environmental sustainability and other ESG-focused corporate projects, disease awareness projects, raising payor awareness of health needs and of the availability of effective innovative technologies to reduce health expenditure and/or ensure optimal care, raising institutional awareness of existing or impending problems and of prevention policies from which society and the health system can benefit. All types of multi-channel communication are included. Examples: video, podcasts and moviemaking, PR and brand storytelling, mobile and apps marketing, insight and market research, data-driven marketing, content marketing, branded experiences and events, search marketing, social media, sponsorship and partner marketing

Projects that have already been submitted for the “Digital ESG strategy” category are also eligible for application in this category when the communication aspects of the project, through social and other digital channels, are prevalent

Animal Health

Purpose: foster the development of innovative solutions for the animal world (both pets and farm animals) through the involvement of the various stakeholders indicated

Target audience: veterinarians, breeders, pharmacists, pet owners, retail companies, institutions

Types and examples: projects that exploit digital technologies to improve the diagnosis and treatment of diseases affecting pets and farm animals, use of innovative tools and languages for updating, training and supporting the veterinary profession. Projects to raise public awareness of animal care and pet therapy, training of pharmacists in animal health, raising awareness of citizens, institutions and payors towards animal health issues. Projects favouring professional synergy between HCPs, in particular between veterinarian and pharmacist. One Health projects combining human, animal and environmental health

Updating and supporting the profession of pharmacists

Purpose: facilitate updating and provide support tools for the practice and profession of pharmacists

Target audience: community and hospital pharmacists

Types and examples: projects that help the management of the pharmacist’s activity, both territorial and hospital. Projects that reduce the risks associated with drug management, particularly at the intra-hospital level.

Projects that promote the role of the service pharmacy, promote the culture of galenic preparations, foster effective collaboration with healthcare managers, doctors, and caregivers, and promote understanding of key digital health tools.

Projects that implement innovative drug distribution practices, promote e-commerce, and counter the phenomenon of fake medicines; projects that promote a One Health culture and help pharmacists involved in animal health work with veterinarians and other stakeholders to optimise pets health

Engagement of the corporate team

Purpose: promote and stimulate the digital transformation of the corporate structure and its various departments by lifescience industries, hospitals and other healthcare entities, through people-focused projects that may involve some or all corporate functions

Target audience: corporate staff from all departments and sectors in lifescience industries, research institutes, healthcare institutions etc.

Types and examples: projects that use innovative technologies to appropriately engage different internal and external stakeholders, to facilitate interaction between different business functions, to optimise internal resources and their management. Projects to promote knowledge and digital culture, projects that adopt innovative approaches to issues relevant to the company, to create and develop engagement of company staff. Wide-ranging change management projects focusing on some or all business functions

Digital Health Partnership

Purpose: Foster partnerships between life science industries and other players in the health care scene, such as start-ups, scientific societies, foundations, patient associations, institutions, universities and research institutes

Target audience: companies and other entities involved in the partnership

Types and examples: Projects to promote the activities of start-up companies through financing, acquisitions and other forms of partnerships; public-private and private-private partnership projects for the promotion of digital health; projects developed within the framework of the PNRR; projects to raise public awareness on topics of crucial interest for the national system; broad-ranging education projects on digital health topics in which the combination of the competences of two or more industrial or public administration partners plays a key role; partnership projects according to definition no. 17 of the WHO Sustainable Development Goals. The importance and main characteristics of the partnership in the development and implementation of the project should be emphasised in the project description

It will be possible to submit projects until 7 December 2023. The forms will be available from September 2023, for more information write to digitalawards@aboutpharma.com

In order to facilitate the work of the jury and the selection from among the candidate projects, the format of the presentation should reflect the following scheme:

  • Reference scenario
  • Project rationale
  • Project objectives and targets
  • Project characteristics and timeframe (describing the originality of the approach, how well and how quickly the project was carried out and the results planned or achieved, and indicating the project start date)
  • Results, even preliminary, at the time of submission of the application

Important Note: If available, attach links to publications of your achievements.

COMPANY AWARDS

BEST SOCIAL COMPANY

Prizes will be awarded to companies that demonstrate an established social media strategy. All pharmaceutical, biotechnology and medical device companies that have submitted at least three projects in three different categories at this year’s AboutPharma Digital Awards will be eligible for the Gold, Silver and Bronze Social Company selection.

All companies interested in participating in this award are required to send a presentation in ppt and pdf format (max. 10 slides) with a description of the company’s business including:

  • Brief Company Profile
  • List of all submitted projects highlighting those with an important social component
  • List of social media covered and results achieved against objectives, targets and KPIs
  • Possible social media tests
  • Indication of internal programs aimed at acquiring social media marketing skills
  • Indication of specific internal policies on the use of social media by employees
  • A successful case history achieved through the integration of communication in the social sphere

The evaluation will be based:

On the data contained in the presentation (creativity of the approach, ability to engage the target audience, ability to hit the targets and achievement of the stated KPIs).

On the votes obtained by the 3 best projects with an important social component presented by the company in the categories.

Registration for the Best Social Company award is free of charge.

BEST DIGITAL COMPANY

Prizes will be awarded to companies that demonstrate a high level of digitisation in various business areas.

All pharmaceutical, biotechnology and medical devices companies that have submitted at least three projects in three different categories at the AboutPharma Digital Awards will be eligible for the Gold, Silver and Bronze Digital Company selection.

All companies interested in participating in this award are required to send a presentation in ppt and pdf format (max. 10 slides) with a description of the company’s business including:

  • Brief Company Profile
  • List of all submitted projects
  • Description of the company’s digitisation path (training, internal training activities etc.)
  • List of all the digital assets used and the results obtained with respect to the objectives, targets and KPIs set
  • A successful case history in one or more business areas (R&D, production, regulatory, quality, marketing, HR etc.)

The evaluation will be based:

On the data contained in the presentation (degree of corporate digitisation at different levels, ability to hit targets and achievement of stated KPIs)

On the votes obtained by the 3 best projects submitted by the company in all categories

Registration for the Best Digital Company award is free of charge.

BEST DIGITAL AGENCY

To compete for Best Digital Agency, it is required to have submitted at least three projects in three different categories at the AboutPharma Digital Awards. The following will be counted

  • projects directly submitted by the agency;
  • projects submitted by another entity (e.g. a pharmaceutical or medical devices industry) for which the name of the agency is listed as project partner together with the submitting entity

All agencies interested in participating as of this year are required to send a presentation in ppt and pdf format (max. 10 slides) with a description of the agency’s activities, including

  • Brief Agency Profile
  • List of all submitted projects
  • Description of the agency’s main characteristics (e.g. local or multinational company, creativity, data insight expertise, ESG characteristics etc)
  • Possible prizes and awards
  • Any other element considered important for the jury’s evaluation

The registration fee for the Best Digital Agency award is €1200 + VAT

PARTECIPATION FEES

For each project submitted, the participation fee is € 370 + VAT.

If the project is submitted in two or more categories, the cost for each additional category is € 270 + VAT.

Registration for the Best Social Company and Best Digital Company awards is free of charge.

The registration fee for the Best Digital Agency award is €1200 + VAT.

Registration in each category entitles the applicant to 1 invitation to the awards evening. Registration for the Best Digital Agency award entitles the applicant to 2 invitations to the awards evening.

Important Note: Only one registration form has to be filled in for each project submitted, even if it applies to more than one category.

For more information write to digitalawards@aboutpharma.com

EVALUATION CRITERIA

Idea: the originality of the idea and the innovativeness of the approach are assessed. It is essential to indicate in the presentation whether the project is an original idea of the Italian team or is a development/adaptation of a project that originated internationally.

Action: the project’s good execution is assessed with particular reference to the ability to involve all stakeholders and the compliance with the predefined timeframe.

Results: the achievement of project objectives is evaluated.

The identification of the evidence for the three evaluation criteria (idea, action, results) is left to the free choice of the applicant who submits the project.

In this edition, for all projects that aim to improve the diagnosis, treatment and quality of life of specific diseases, applicants will be asked to indicate the therapeutic area(s) covered by the project. This will allow the jury to evaluate the applications even more accurately on the basis of the intrinsic characteristics of the project.

Below are some examples of results evaluation parameters in the different categories:

  • Tangible indicators of improvement in vocational training
  • Indices of improvement in clinical practice (facilitation of diagnosis, improvement of adherence to therapy, improvement of patients’ quality of life, facilitation of caregiver tasks)
  • Disease-specific results (improved management of common diseases such as diabetes, COPD, ischaemic heart disease or rare diseases)
  • Socio-health and/or economic improvements (speeding up administrative procedures, reducing the number of hospitalisations, reducing the costs of managing a disease, etc.)
  • Other project performance indicators

For projects in which the digital component of target audience engagement is relevant, it is recommended to indicate benchmark KPIs for websites, apps, social networks

HPS S.r.l.

Sede di Milano
Piazza Duca D’Aosta, 12
20124 Milano
P.IVA 07106000966
Sede di Roma 
Viale dell’Arte, 25
00144 Roma

Per informazioni scrivere a

digitalawards@aboutpharma.com
Tel +39 022772991

AboutPharma Digital Awards è un brand di HPS